{
    "summary": "The Scientific External Process for Educated Review of Therapeutics Act of 2025 (Scientific EXPERT Act) aims to establish a process for science-focused drug development meetings led by the Reagan-Udall Foundation for the Food and Drug Administration. These meetings will involve experts, drug sponsors, and patient organizations to discuss challenges and identify approaches for developing drugs for rare diseases and conditions. The bill mandates the Secretary of Health and Human Services to implement the process, including the establishment of a steering committee, meeting requirements, post-meeting reports, and an annual report to Congress on its impact. It also includes appropriations for funding.",
    "tags": [
        "Healthcare",
        "Healthcare access",
        "Consumer protection",
        "Transparency",
        "Federal agency action",
        "Opioid crisis"
    ],
    "category": "Healthcare & Public Health"
}